Chemical icons Olin and Huntsman to merge
Olin and Huntsman agreed to merge in a “merger of equals,” creating a diversified US chemical company, OlinHuntsman, with about $12.5 billion in annual sales. Olin reported $6.8 billion sales in 2025; Huntsman $5.7 billion. Shareholders will own 54.5% (Olin) and 45.5% (Huntsman). The companies expect first-half next year closing and project $400 million in synergies.
Deal terms and expected synergies create a near-term repricing risk for OLN as investors assess integration and financing needs.
Olin agreed to a merger of equals with Huntsman, with Olin shareholders receiving 54.5% of the combined OlinHuntsman.
Likely volatility higher around deal mechanics (exchange ratio, regulatory/closing risk), with direction dependent on perceived synergy credibility.
Background
The article frames the transaction as a merger of equals combining Olin’s chlor-alkali and related raw materials with Huntsman’s downstream polyurethane and performance/advanced materials businesses.
Why it matters
The disclosed ownership split (54.5%/45.5%), expected close window (H1 next year), and management-stated $400M cost savings are the key new deal-specific inputs that can drive valuation and merger-arb positioning for both issuers.
Market relevance
A large, strategic M&A deal with explicit synergy targets and vertical integration linkages is likely to drive near-term volatility and merger-arb interest in both names.
Market effects
Vertical integration in chlor-alkali and downstream specialty/polyurethane inputs could shift competitive dynamics and bargaining power across chemical supply chains.
Headquarters in Woodlands, Texas may concentrate operational focus in the US Gulf/industrial corridor, though the article provides no incremental regional capex details.
If realized, the $400M synergy and input integration could affect global pricing/availability for chlorine-linked intermediates (e.g., phosgene/MDI feedstocks).
Alternative perspectives
The market’s immediate tepid reaction (both stocks down) suggests investors may doubt the $400M synergy or worry about integration complexity, leaving downside risk despite the strategic logic.
No divestitures are earmarked; traders may need to underwrite potential antitrust/regulatory scrutiny and the risk that keeping all segments (including advanced materials and Winchester) limits optimization.
Key entities
- companyOlin
US chemical producer; chlor-alkali and related raw materials plus Winchester ammunition business.
- companyHuntsman
US chemical company; largest segment is polyurethane (MDI) plus performance products and advanced materials.
- companyOlinHuntsman
Proposed combined entity headquartered in Woodlands, Texas, with Olin CEO Ken Lane as CEO and Peter Huntsman as chairman.
